These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27638233)

  • 1. Progression of Renal Impairment and Chronic Kidney Disease in Chronic Heart Failure: An Analysis From GISSI-HF.
    Damman K; Masson S; Lucci D; Gorini M; Urso R; Maggioni AP; Tavazzi L; Tarantini L; Tognoni G; Voors A; Latini R
    J Card Fail; 2017 Jan; 23(1):2-9. PubMed ID: 27638233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study).
    Shepherd J; Breazna A; Deedwania PC; LaRosa JC; Wenger NK; Messig M; Wilson DJ;
    Am J Cardiol; 2016 Apr; 117(8):1199-205. PubMed ID: 26940556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Effect of Renal Function in Ambulatory Patients With Heart Failure and Reduced Ejection Fraction: The Kidney Is a Marker of Cardiac Function.
    Mascarenhas J; Laszczynska O; Severo M; Friões F; Alvelos M; Bettencourt P; Pimenta J; Azevedo A
    Can J Cardiol; 2018 Oct; 34(10):1325-1332. PubMed ID: 30201253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
    Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Vidt DG; Ridker PM; Monyak JT; Schreiber MJ; Cressman MD
    Clin Ther; 2011 Jun; 33(6):717-25. PubMed ID: 21704236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study.
    Lesogor A; Cohn JN; Latini R; Tognoni G; Krum H; Massie B; Zalewski A; Kandra A; Hua TA; Gimpelewicz C
    Eur J Heart Fail; 2013 Nov; 15(11):1236-44. PubMed ID: 23787721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function.
    George LK; Koshy SKG; Molnar MZ; Thomas F; Lu JL; Kalantar-Zadeh K; Kovesdy CP
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28765150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.
    Bansal N; Zelnick L; Bhat Z; Dobre M; He J; Lash J; Jaar B; Mehta R; Raj D; Rincon-Choles H; Saunders M; Schrauben S; Weir M; Wright J; Go AS;
    J Am Coll Cardiol; 2019 Jun; 73(21):2691-2700. PubMed ID: 31146814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study).
    Ho JE; Waters DD; Kean A; Wilson DJ; Demicco DA; Breazna A; Wun CC; Deedwania PC; Khush KK;
    Am J Cardiol; 2012 Jun; 109(12):1761-6. PubMed ID: 22459310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia.
    Calza L; Colangeli V; Borderi M; Manfredi R; Marconi L; Bon I; Re MC; Viale P
    HIV Clin Trials; 2018 Jun; 19(3):120-128. PubMed ID: 29770749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of renal function before and after percutaneous mitral valve repair.
    Wang A; Sangli C; Lim S; Ailawadi G; Kar S; Herrmann HC; Grayburn P; Foster E; Weissman NJ; Glower D; Feldman T
    Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25593120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
    McAlister FA; Ezekowitz J; Tarantini L; Squire I; Komajda M; Bayes-Genis A; Gotsman I; Whalley G; Earle N; Poppe KK; Doughty RN;
    Circ Heart Fail; 2012 May; 5(3):309-14. PubMed ID: 22441773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
    Ghali JK; Wikstrand J; Van Veldhuisen DJ; Fagerberg B; Goldstein S; Hjalmarson A; Johansson P; Kjekshus J; Ohlsson L; Samuelsson O; Waagstein F; Wedel H;
    J Card Fail; 2009 May; 15(4):310-8. PubMed ID: 19398079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function in heart failure: a disparity between estimating function and predicting mortality risk.
    Plischke M; Neuhold S; Kohl M; Heinze G; Sunder-Plassmann G; Pacher R; Hülsmann M
    Eur J Heart Fail; 2013 Jul; 15(7):763-70. PubMed ID: 23429976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?
    Ravassa S; Beaumont J; Cediel G; Lupón J; López B; Querejeta R; Díez J; Bayés-Genís A; González A
    Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):835-843. PubMed ID: 31948893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.